pargyline has been researched along with Cardiomyopathies, Primary in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with propranolol and pargyline protected against ISO-induced necrosis and myocardial hypertrophy, but did not influence the ISO-induced depletion of NE stores." | 1.25 | Alterations in norepinephrine pattern in the damaged myocardium in the rat. ( Bhagat, B; Dhalla, NS; Sullivan, JM, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhagat, B | 1 |
| Sullivan, JM | 1 |
| Dhalla, NS | 1 |
| Sole, MJ | 1 |
| Shum, A | 1 |
| Van Loon, GR | 1 |
2 other studies available for pargyline and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Alterations in norepinephrine pattern in the damaged myocardium in the rat.
Topics: Animals; Cardiomegaly; Cardiomyopathies; Isoproterenol; Male; Monoamine Oxidase; Myocardium; Necrosi | 1975 |
Serotonin metabolism in the normal and failing hamster heart.
Topics: Animals; Cardiomyopathies; Cricetinae; Dihydroxytryptamines; Female; Heart Failure; Humans; Hydroxyd | 1979 |